OSMUNDA
OSMUNDA Group is the leading clinical trial CRO and service provider of medical devices and pharmaceuticals.
$14.99M Series B+ ·
Led by Zhejiang Peking University Collaborative Innovation Investment Management · Source: news.pedaily.cn
Funding history ↓Signals
Website registeredAug 24, 2004 (22 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $14.99M |  ZZhejiang Peking University Collaborative Innovation Investment Management | news.pedaily.cn |
Timeline
- Website created
Team
- WZwei zhang Project Manager
Investors
Companies like OSMUNDA
CClinChoice$150M Series B+ · Jul 2022
AAurasenseAAidoc$150M Series B+ · Apr 2026
RRheos MedicalSeed · Oct 2026
MMilundaSeed · Aug 2026
MMedCompli
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/osmunda (get a free API key).